文献速递肾移植

移植中心患者导航员对高危人群肾移植可及性的随机对照试验

Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population: A Randomized, Controlled Trial.
PubMed 文献 · Clin J Am Soc Nephrol · 2018-03-26

单中心随机对照试验纳入401例转诊肾移植评估患者,干预组由导航员协助。总体等待名单登记率干预组32%对对照组26%无显著差异(P=0.17),但500天后干预组等待登记可能性为对照组3.3倍(75%对25%;HR 3.31;95%CI 1.20-9.12)。

要点

  • 导航员干预未显著提高总体等待名单登记率(32%对26%,P=0.17)。
  • 随访500天后干预组等待登记率显著更高(75%对25%;HR 3.31)。
  • 干预组活体供者咨询更多(18%对10%,P=0.03)。

核心结论

  • 移植中心导航员可改善高危患者等待名单登记,但效应在500天后才显现,绝对效应较小。

研究设计与样本

  • 单中心随机对照试验,纳入401例转诊肾移植评估患者(干预组196例,对照组205例),2013年1月至2014年8月转诊,随访至2016年5月。

主要发现

  • 总体等待名单登记率干预组32%对对照组26%,差异无统计学意义(P=0.17)。
  • 转诊至等待登记时间干预组比对照组长126天。
  • 早期(转诊后<500天)等待登记率两组均为50%(HR 1.03;95%CI 0.69-1.53)。
  • 晚期(≥500天)干预组等待登记率75%对对照组25%(HR 3.31;95%CI 1.20-9.12)。
  • 开始评估率85%对79%(P=0.11)、完成评估率58%对51%(P=0.14)均无显著差异;活体供者咨询率18%对10%(P=0.03)。

临床怎么用

  • 对于高危肾移植候选者,可考虑移植中心导航员干预,但需关注其效应延迟且绝对获益有限。

局限性

  • 单中心研究,可能限制普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Barriers exist in access to kidney transplantation, where minority and patients with low socioeconomic status are less likely to complete transplant evaluation. The purpose of this study was to examine the effectiveness of a transplant center-based patient navigator in helping patients at high risk of dropping out of the transplant evaluation process access the kidney transplant waiting list. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: We conducted a randomized, controlled trial of 401 patients (n=196 intervention and n=205 control) referred for kidney transplant evaluation (January 2013 to August 2014; followed through May 2016) at a single center. A trained navigator assisted intervention participants from referral to waitlisting decision to increase waitlisting (primary outcome) and decrease time from referral to waitlisting (secondary outcome). Time-dependent Cox proportional hazards models were used to determine differences in waitlisting between intervention and control patients. RESULTS: At study end, waitlisting was not significantly different among intervention (32%) versus control (26%) patients overall (P=0.17), and time from referral to waitlisting was 126 days longer for intervention patients. However, the effectiveness of the navigator varied from early (<500 days from referral) to late (≥500 days) follow-up. Although no difference in waitlisting was observed among intervention (50%) versus control (50%) patients in the early period (hazard ratio, 1.03; 95% confidence interval, 0.69 to 1.53), intervention patients were 3.3 times more likely to be waitlisted after 500 days (75% versus 25%; hazard ratio, 3.31; 95% confidence interval, 1.20 to 9.12). There were no significant differences in intervention versus control patients who started evaluation (85% versus 79%; P=0.11) or completed evaluation (58% versus 51%; P=0.14); however, intervention patients had more living donor inquiries (18% versus 10%; P=0.03). CONCLUSIONS: A transplant center-based navigator targeting disadvantaged patients improved waitlisting but not until after 500 days of follow-up. However, the absolute effect was relatively small.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Basu M, Petgrave-Nelson L, Smith KD, et al. Transplant Center Patient Navigator and Access to Transplantation among High-Risk Population: A Randomized, Controlled Trial. Clin J Am Soc Nephrol. 2018. PMID: 29581107. doi:10.2215/CJN.08600817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。